Product Code: ETC13408472 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
Global Biosimilars Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Biosimilars Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Biosimilars Market Revenues & Volume, 2021 & 2031F |
3.3 Global Biosimilars Market - Industry Life Cycle |
3.4 Global Biosimilars Market - Porter's Five Forces |
3.5 Global Biosimilars Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Biosimilars Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Global Biosimilars Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Global Biosimilars Market Revenues & Volume Share, By Manufacturing, 2021 & 2031F |
4 Global Biosimilars Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Biosimilars Market Trends |
6 Global Biosimilars Market, 2021 - 2031 |
6.1 Global Biosimilars Market, Revenues & Volume, By Product, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Biosimilars Market, Revenues & Volume, By Insulin, 2021 - 2031 |
6.1.3 Global Biosimilars Market, Revenues & Volume, By Follitropin, 2021 - 2031 |
6.1.4 Global Biosimilars Market, Revenues & Volume, By Calcitonin, 2021 - 2031 |
6.1.5 Global Biosimilars Market, Revenues & Volume, By Glucagon, 2021 - 2031 |
6.1.6 Global Biosimilars Market, Revenues & Volume, By Teriparatide, 2021 - 2031 |
6.1.7 Global Biosimilars Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Biosimilars Market, Revenues & Volume, By Indication, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Biosimilars Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.2.3 Global Biosimilars Market, Revenues & Volume, By Offsite Treatment, 2021 - 2031 |
6.2.4 Global Biosimilars Market, Revenues & Volume, By Chronic Disorders, 2021 - 2031 |
6.2.5 Global Biosimilars Market, Revenues & Volume, By Blood Disorders, 2021 - 2031 |
6.2.6 Global Biosimilars Market, Revenues & Volume, By Infectious Diseases, 2021 - 2031 |
6.2.7 Global Biosimilars Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Biosimilars Market, Revenues & Volume, By Manufacturing, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Biosimilars Market, Revenues & Volume, By Outsourced, 2021 - 2031 |
6.3.3 Global Biosimilars Market, Revenues & Volume, By In-house, 2021 - 2031 |
7 North America Biosimilars Market, Overview & Analysis |
7.1 North America Biosimilars Market Revenues & Volume, 2021 - 2031 |
7.2 North America Biosimilars Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Biosimilars Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Biosimilars Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Biosimilars Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Biosimilars Market, Revenues & Volume, By Product, 2021 - 2031 |
7.4 North America Biosimilars Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.5 North America Biosimilars Market, Revenues & Volume, By Manufacturing, 2021 - 2031 |
8 Latin America (LATAM) Biosimilars Market, Overview & Analysis |
8.1 Latin America (LATAM) Biosimilars Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Biosimilars Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Biosimilars Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Biosimilars Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Biosimilars Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Biosimilars Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Biosimilars Market, Revenues & Volume, By Product, 2021 - 2031 |
8.4 Latin America (LATAM) Biosimilars Market, Revenues & Volume, By Indication, 2021 - 2031 |
8.5 Latin America (LATAM) Biosimilars Market, Revenues & Volume, By Manufacturing, 2021 - 2031 |
9 Asia Biosimilars Market, Overview & Analysis |
9.1 Asia Biosimilars Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Biosimilars Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Biosimilars Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Biosimilars Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Biosimilars Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Biosimilars Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Biosimilars Market, Revenues & Volume, By Product, 2021 - 2031 |
9.4 Asia Biosimilars Market, Revenues & Volume, By Indication, 2021 - 2031 |
9.5 Asia Biosimilars Market, Revenues & Volume, By Manufacturing, 2021 - 2031 |
10 Africa Biosimilars Market, Overview & Analysis |
10.1 Africa Biosimilars Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Biosimilars Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Biosimilars Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Biosimilars Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Biosimilars Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Biosimilars Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Biosimilars Market, Revenues & Volume, By Product, 2021 - 2031 |
10.4 Africa Biosimilars Market, Revenues & Volume, By Indication, 2021 - 2031 |
10.5 Africa Biosimilars Market, Revenues & Volume, By Manufacturing, 2021 - 2031 |
11 Europe Biosimilars Market, Overview & Analysis |
11.1 Europe Biosimilars Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Biosimilars Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Biosimilars Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Biosimilars Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Biosimilars Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Biosimilars Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Biosimilars Market, Revenues & Volume, By Product, 2021 - 2031 |
11.4 Europe Biosimilars Market, Revenues & Volume, By Indication, 2021 - 2031 |
11.5 Europe Biosimilars Market, Revenues & Volume, By Manufacturing, 2021 - 2031 |
12 Middle East Biosimilars Market, Overview & Analysis |
12.1 Middle East Biosimilars Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Biosimilars Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Biosimilars Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Biosimilars Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Biosimilars Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Biosimilars Market, Revenues & Volume, By Product, 2021 - 2031 |
12.4 Middle East Biosimilars Market, Revenues & Volume, By Indication, 2021 - 2031 |
12.5 Middle East Biosimilars Market, Revenues & Volume, By Manufacturing, 2021 - 2031 |
13 Global Biosimilars Market Key Performance Indicators |
14 Global Biosimilars Market - Export/Import By Countries Assessment |
15 Global Biosimilars Market - Opportunity Assessment |
15.1 Global Biosimilars Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Biosimilars Market Opportunity Assessment, By Product, 2021 & 2031F |
15.3 Global Biosimilars Market Opportunity Assessment, By Indication, 2021 & 2031F |
15.4 Global Biosimilars Market Opportunity Assessment, By Manufacturing, 2021 & 2031F |
16 Global Biosimilars Market - Competitive Landscape |
16.1 Global Biosimilars Market Revenue Share, By Companies, 2024 |
16.2 Global Biosimilars Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |